PPIG and metabolic dysfunction-associated steatotic liver disease: Although lipidomic analyses in humans have demonstrated that NAFLD/NASH is associated with dysregulated fatty acid metabolism, [37] the relationship between the presence and severity of NAFLD/NASH and altered CYP-derived eicosanoid metabolites has not been evaluated in humans to date.